tioncytologyofcysticcervicallymphnodemetastasisfrompapillarythy-roidcarcinoma［J］．DiagnCytopathol，2022，50(7):350－356．［4］HaugenBＲ，AlexanderEK，BibleKC，etal．2015Americanthyroidassociationmanagementguidelinesforadultpatientswiththyroidnodulesanddifferentiatedthyroidcancer:TheAmericanthyroidassociationguidelinestaskforceonthyroidnodulesanddifferentiatedthyroidcancer［J］．Thyroid，2016，26(1):1－133．［5］LeenhardtL，ErdoganMF，HegedusL，etal．2013Europeanthyroidassociationguidelinesforcervicalultrasoundscanandultrasound－guidedtechniquesinthepostoperativemanagementofpatientswiththy-roidcancer［J］．EurThyroidJ，2013，2(3):147－159．［6］WangJ，JiangX，XiaoG，etal．ExcellentdiagnosticperformanceofFNA－tgindetectinglymphnodesmetastasesfrompapillarythyroidcancer［J］．FutureOncol(LondEngl)．2020，16(33):2735－2746．［7］柴吉鑫，齐艳涛，王婧婧，等．细针穿刺细胞学联合洗脱液甲状腺球蛋白检测对甲状腺癌颈部淋巴结转移诊断价值［J］．河北医学，2022，28(3):390－394．［8］MegwaluU，MoonPK．ThyroidCancerIncidenceandMortalityTrendsintheUnitedStates:2000－2018［J］．Thyroid，2022，32(5):560－570．［9］KimDH，KimGJ，KimSW，etal．Predictivevalueofipsilateralcentrallymphnodemetastasisforcontralateralcentrallymphnodemetastasisinpatientswiththyroidcancer:Systematicreviewandmeta－analysis［J］．HeadNeck，2021，43(10):3177－3184．［10］FengJW，QinAC，YeJ，etal．PredictiveFactorsforLateralLymphNodeMetastasisandSkipMetastasisinPapillaryThyroidCarcinoma［J］．EndocrPathol，2020，31(1):67－76．［11］SanabriaA，BetancourtC，SánchezJG，etal．ProphylacticCentralNeckLymphNodeDissectioninLow－ＲiskThyroidCarcinomaPatientsDoesnotDecreasetheIncidenceofLocoregionalＲecurrence:AMeta－Analy-sisofＲandomizedTrials［J］．AnnSurg，2022，276(1):66－73．［12］AhnJH，KwakJH，YoonSG，etal．Aprospectiverandomizedcon-trolledtrialtoassesstheefficacyandsafetyofprophylacticcentralcom-partmentlymphnodedissectioninpapillarythyroidcarcinoma［J］．Sur-gery，2022，171(1):182－189．［13］JiaX，WangY，LiuY，e...
